WisdomTree BioRevolution Fund (WDNA)
Holdings data is not available for this fund yet.
WDNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Sept. 30, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +3.93% | ▲ +3.93% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +12.70% | ▲ +12.70% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 81 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| DANAHER CORP | 235851102 | $20K | 0.75 | 105 | EC | US |
| REPLIGEN CORP | 759916109 | $19K | 0.72 | 142 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $19K | 0.70 | 146 | EC | US |
| SANA BIOTECHNOLOGY INC | 799566104 | $18K | 0.67 | 5,156 | EC | US |
| VERBIO VEREINIGTE BIOENERGIE SE | · | $18K | 0.66 | 520 | EC | DE |
| HALOZYME THERAPEUTICS INC | 40637H109 | $17K | 0.65 | 222 | EC | US |
| ULTRAGENYX PHARMACEUTICAL INC | 90400D108 | $16K | 0.60 | 479 | EC | US |
| SYENSQO SA/NV | · | $16K | 0.59 | 214 | EC | BE |
| FMC CORP | 302491303 | $16K | 0.58 | 1,357 | EC | US |
| INSMED INC | 457669307 | $16K | 0.58 | 146 | EC | US |
| GREEN PLAINS INC | 393222104 | $16K | 0.58 | 1,010 | EC | US |
| ARCTURUS THERAPEUTICS HOLDINGS INC | 03969T109 | $15K | 0.55 | 2,185 | EC | US |
| ILLUMINA INC | 452327109 | $14K | 0.54 | 82 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $14K | 0.54 | 23 | EC | US |
| INTELLIA THERAPEUTICS INC | 45826J105 | $14K | 0.53 | 841 | EC | US |
| NUFARM LTD | · | $13K | 0.50 | 7,097 | EC | AU |
| BIO-TECHNE CORP | 09073M104 | $13K | 0.49 | 185 | EC | US |
| BRIDGEBIO PHARMA INC | 10806X102 | $13K | 0.48 | 172 | EC | US |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | $12K | 0.44 | 204 | EC | US |
| GENMAB A/S | 372303206 | $11K | 0.42 | 408 | EC | DK |
| OXFORD NANOPORE TECHNOLOGIES PLC | · | $11K | 0.40 | 6,496 | EC | GB |
| ZOETIS INC | 98978V103 | $10K | 0.36 | 135 | EC | US |
| GENUS PLC | · | $9K | 0.34 | 320 | EC | GB |
| GERON CORP | 374163103 | $9K | 0.33 | 6,841 | EC | US |
| TYSON FOODS INC | 902494103 | $8K | 0.30 | 138 | EC | US |
| ROCKET PHARMACEUTICALS INC | 77313F106 | $8K | 0.30 | 2,310 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $8K | 0.29 | 26 | EC | US |
| SAREPTA THERAPEUTICS INC | 803607100 | $8K | 0.28 | 419 | EC | US |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | 69404D108 | $7K | 0.26 | 4,222 | EC | US |
| QIAGEN NV | · | $7K | 0.25 | 172 | EC | NL |
| DREYFUS TRSY OBLIG CASH M | · | $3K | 0.11 | 2,870 | STIV | US |
Dividends 5 payments
| Ex-date | Amount / share |
|---|---|
| Dec. 26, 2025 | $0.7710 |
| Dec. 26, 2024 | $0.1070 |
| Dec. 22, 2023 | $0.1350 |
| Dec. 23, 2022 | $0.0650 |
| Dec. 27, 2021 | $0.0250 |
Institutional owners (13F) 3 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| LANARK FINANCIAL, INC. | $12,315 | 65.00% | 598 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $4,632 | 24.45% | 225 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $2,000 | 10.56% | 100 | Shares | June 30, 2026 |